1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow HIV 1 Infection: new trials by email Literature Review of HIV 1 Infection trials Research Report on HIV 1 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE Bictegravir, emtricitabine, and tenofovir alafenamide - HIV -1 Infection, HIV (Human Immunodeficiency Virus) | Phase 4 | Recruiting | CAN Community Health | 200 | 2026-06-17 | 2026-11-16 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Slow Virus Diseases (1) · Urogenital Diseases (1) · Virus Diseases (1)
bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)
United States (1)
Hector Bolivar, MD (1) · Jessica Altamirano, MD (1)